You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Roche CARDIAC proBNP plus IVD Roche CARDIAC proBNP+ CPS_000890 N-terminal pro B-type natriuretic peptide 05 533 643 190 5 533 643 190 05533643190 5533643190 05533643190 Roche Cardiac proBNP+ 10 tests (cobas) Roche CARDIAC proBNP+ 04015630927654 Reagents, kits 10 tests cobas h 232 true 05 533 643 191 5 533 643 191 05533643191 5533643191 05533643191 Roche Cardiac proBNP+ 10 tests (cobas) Roche CARDIAC proBNP+ 07613336189030 Reagents, kits 10 tests cobas h 232 ms_05533724001 Roche CARDIAC proBNP+ N-terminal pro B-type natriuretic peptide en 4 FF000000000F890E FF000000000F890E 05533643190 1011 cobas h 232 1012 cobas h 232 scanner version Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of NT‑proBNP in heparinised venous blood for use with the cobas h 232 instrument. The Roche CARDIAC proBNP+ test serves as an aid in the diagnosis of patients with suspected heart failure, in the monitoring of patients with compensated left ventricular dysfunction and in the risk stratification of patients with acute coronary syndromes. en 05533724001 Roche CARDIAC proBNP+ N-terminal pro B-type natriuretic peptide en 6 FF000000065AD80E FF0000000243470E 05533643190 1011 cobas h 232 1012 cobas h 232 scanner version Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use The Roche CARDIAC proBNP+ is an in vitro diagnostic test for the quantitative determination of NT‑proBNP in heparinised venous blood for use with the cobas h 232 instrument. The Roche CARDIAC proBNP+ test serves as an aid in the diagnosis of patients with suspected heart failure, in the monitoring of patients with compensated left ventricular dysfunction and in the risk stratification of patients with acute coronary syndromes. The test is intended for near‑patient testing.Not for self-testing. en